{"as_of":"2026-08-14T23:49:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:6c8f36216e4b6e6df9cc9fbc077a0c26b2588500e74bdf52953c21f5d895bf7f","coverage":[{"denominator":41,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":41,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-14T04:16:27.593627Z","state":"measured"},{"denominator":41,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":41,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-14T06:32:32.682623+00:00","state":"measured"},{"denominator":0,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"cited_works","source_observed_at":null,"state":"measured"}],"external_citation_measurements":[],"inbound":[],"links":{"evidence":"/evidence","html":"/paper/2608.10175/citation-record","integrity":"/paper/2608.10175/integrity","json":"/paper/2608.10175/citation-record.json","paper":"/paper/2608.10175"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:27.397283Z","title":"and Cai, Carrie J","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":1,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.397283Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:a36d752211a340eb389ea78e4dfe29a642b635e88ffa5c03ecf79a0855d034a9","observation_id":"64ad8f04-2620-4a95-a07c-37ad5f50c04f","resolution":{"observed_at":"2026-08-14T04:16:27.397283Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.480855Z","title":"and Burger, Doug and Wang, Chi , title =","venue":null,"work_id":"d1ea0186-6d40-4662-9b2f-2fe088cd67a8","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":2,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.404585Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:7d204c6f76e62f7db0fc7369a45fddfa41eb08e35d6829b3fb4d51846f3495d8","observation_id":"4b61d1db-f163-454b-b6aa-66793efc048e","resolution":{"observed_at":"2026-08-14T04:16:28.485922Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.442721Z","title":"International Conference on Learning Representations (ICLR) , year =","venue":null,"work_id":"61f6796c-f0eb-4e7c-b1b9-b1607f32ee7e","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":3,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.409288Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:56dff63c402eee0172fe6b1c2049655a68735154d5566f33c99e84cfc3582999","observation_id":"d844e779-a4b5-4418-9c29-4435501c8d11","resolution":{"observed_at":"2026-08-14T04:16:28.449236Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:27.413728Z","title":"and Mordatch, Igor , title =","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":4,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.413728Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:b196bac5883d23879b233944169a763c5bbc73afeeb1685bd87e3f8acabb35fc","observation_id":"1c2f90c8-e224-46da-93a5-5a5d94e348a5","resolution":{"observed_at":"2026-08-14T04:16:27.413728Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.382857Z","title":"and Wiest, Olaf and Zhang, Xiangliang , title =","venue":null,"work_id":"b10900f2-8714-4197-91e6-950f86093cfa","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":5,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.417988Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:3c541849db9b2addbeede3f09c04beaba8b150f1e0d6d5ec94bf4ca876e3d377","observation_id":"d960c292-eafa-4fa8-950a-21d86edd16c9","resolution":{"observed_at":"2026-08-14T04:16:28.388442Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.359417Z","title":"and Le, Quoc V","venue":null,"work_id":"c9ac7dd6-0ce9-4df8-86b5-c209742785d3","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":6,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.422065Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:e19322908012bab454d4afaf9950c506548c86abef46b940fb71c7573e92634e","observation_id":"e925d6d7-c462-4e2b-993b-7f664d5ab8f3","resolution":{"observed_at":"2026-08-14T04:16:28.367664Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.326472Z","title":"ACM Computing Surveys , volume =","venue":null,"work_id":"79623be9-f6b2-4b80-adc5-3b42df11dff8","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":7,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.427080Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:86c94c729eb38b0c859485d433ca766979f4c134dd2d2438bed972ce4d03746c","observation_id":"428288cf-962d-4286-aaf2-5275c4e740dd","resolution":{"observed_at":"2026-08-14T04:16:28.336748Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2412.20138","last_updated":"2025-06-03T05:45:06Z","snapshot_observed_at":"2026-08-10T23:28:38.223456Z","submitted_at":"2024-12-28T12:54:06Z","title":"TradingAgents: Multi-Agents LLM Financial Trading Framework","version":7},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2412.20138","snapshot_observed_at":"2026-08-14T04:16:27.431053Z","title":"arXiv preprint arXiv:2412.20138 , year =","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":8,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.431053Z"},"links":{"cited_paper":"/paper/2412.20138","citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:ab1e47137e978c5ed17a64a3d573d4723076cc1e521ceb499fcb6f500cbf158f","observation_id":"62d690cb-ec19-4616-a78c-f0e695f94a5e","resolution":{"observed_at":"2026-08-14T04:16:27.431053Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.298022Z","title":"2024 , url =","venue":null,"work_id":"f36fd6b4-8f9d-480f-b78b-adb7fffed992","year":2024},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":9,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.435387Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:01c73942d063f0a51ffb13e720aa06a41a53a67905614f0ecf2cbb20bbb5af26","observation_id":"cf3ad5a8-8050-4467-9c3c-54b89728c97b","resolution":{"observed_at":"2026-08-14T04:16:28.305569Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2508.11152","last_updated":"2025-08-15T01:49:56Z","snapshot_observed_at":"2026-08-05T20:06:53.323757Z","submitted_at":"2025-08-15T01:49:56Z","title":"AlphaAgents: Large Language Model based Multi-Agents for Equity Portfolio Constructions","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2508.11152","snapshot_observed_at":"2026-08-14T04:16:27.439970Z","title":"arXiv preprint arXiv:2508.11152 , year =","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":10,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.439970Z"},"links":{"cited_paper":"/paper/2508.11152","citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:fbda316235874ca5292684b764cd799ff308e62b4aa4b0323f0582b6676686bd","observation_id":"dafdf8ae-6ab0-435f-9e9c-b23fe155dd82","resolution":{"observed_at":"2026-08-14T04:16:27.439970Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2411.08804","last_updated":"2024-11-13T17:38:07Z","snapshot_observed_at":"2026-08-14T08:33:42.769182Z","submitted_at":"2024-11-13T17:38:07Z","title":"FinRobot: AI Agent for Equity Research and Valuation with Large Language Models","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2411.08804","snapshot_observed_at":"2026-08-14T04:16:27.444656Z","title":"arXiv preprint arXiv:2411.08804 , year =","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":11,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.444656Z"},"links":{"cited_paper":"/paper/2411.08804","citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:44485e813b9f15ac3aaae75a2de7c4c689f321f32985d125707c1e3f9a99ba48","observation_id":"43a26775-85f1-4401-a935-4e811fc41739","resolution":{"observed_at":"2026-08-14T04:16:27.444656Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.281116Z","title":"and Khashanah, Khaldoun , title =","venue":null,"work_id":"edacc804-76a4-47bf-97a3-deaa44287cde","year":2024},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":12,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.449125Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:e3b908112584aa2c5811f4a5cb59676ed044455014370155c5286a4ce8377cc9","observation_id":"b3464075-24fc-46e3-afce-224efe80f50c","resolution":{"observed_at":"2026-08-14T04:16:28.285383Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2309.03736","last_updated":"2023-09-07T14:25:35Z","snapshot_observed_at":"2026-08-13T10:18:30.805761Z","submitted_at":"2023-09-07T14:25:35Z","title":"TradingGPT: Multi-Agent System with Layered Memory and Distinct Characters for Enhanced Financial Trading Performance","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2309.03736","snapshot_observed_at":"2026-08-14T04:16:27.453401Z","title":"arXiv preprint arXiv:2309.03736 , year =","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":13,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.453401Z"},"links":{"cited_paper":"/paper/2309.03736","citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:861df1b3a82a2cba4df180960b47820c1ad0889a9b4a648e10c94ae8ab96855a","observation_id":"23dcb5ef-1c37-4d10-bcb8-d747561bba66","resolution":{"observed_at":"2026-08-14T04:16:27.453401Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2303.17564","last_updated":"2023-12-21T06:21:11Z","snapshot_observed_at":"2026-08-14T12:54:48.492396Z","submitted_at":"2023-03-30T17:30:36Z","title":"BloombergGPT: A Large Language Model for Finance","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2303.17564","snapshot_observed_at":"2026-08-14T04:16:27.457884Z","title":"arXiv preprint arXiv:2303.17564 , year =","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":14,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.457884Z"},"links":{"cited_paper":"/paper/2303.17564","citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:5adb03e87739484ce4fa0784b13d55efb4859434145fb949f97a33b5c7153c81","observation_id":"0339efc9-769f-40c7-8bae-4472b2d2ee1f","resolution":{"observed_at":"2026-08-14T04:16:27.457884Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:27.462229Z","title":"arXiv preprint arXiv:2306.06031 , year =","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":15,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.462229Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:f9005f4f28886d14edac4f3effe18bf3bcbff0092db80ef853ba8e52acf7e7a2","observation_id":"7f7e0dba-dba8-41ed-bdce-6a120d062097","resolution":{"observed_at":"2026-08-14T04:16:27.462229Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2506.04293","last_updated":"2025-06-04T11:50:55Z","snapshot_observed_at":"2026-08-09T18:54:37.255091Z","submitted_at":"2025-06-04T11:50:55Z","title":"AUTOCT: Automating Interpretable Clinical Trial Prediction with LLM Agents","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2506.04293","snapshot_observed_at":"2026-08-14T04:16:27.466387Z","title":", title =","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":16,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.466387Z"},"links":{"cited_paper":"/paper/2506.04293","citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:61f1620e9a5c9370856209b7d1501e0517add336e336d864358728b707e69df1","observation_id":"f9471168-3d9e-4258-8cf7-8508f857f6a2","resolution":{"observed_at":"2026-08-14T04:16:27.466387Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2406.06316","last_updated":"2024-06-10T14:33:02Z","snapshot_observed_at":"2026-08-12T23:46:25.673620Z","submitted_at":"2024-06-10T14:33:02Z","title":"Tx-LLM: A Large Language Model for Therapeutics","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2406.06316","snapshot_observed_at":"2026-08-14T04:16:27.470996Z","title":"Sara and Semturs, Christopher and Fleet, David and Natarajan, Vivek and Azizi, Shekoofeh , title =","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":17,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.470996Z"},"links":{"cited_paper":"/paper/2406.06316","citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:cdcc2aa414705a174ab3e4cf6b719a83650346f9b582735748228a801829ce45","observation_id":"3514d047-426a-4544-90cd-cb947e7ba099","resolution":{"observed_at":"2026-08-14T04:16:27.470996Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.264934Z","title":"2024 , url =","venue":null,"work_id":"179a1c18-c56e-4f3e-be48-b36872a84b80","year":2024},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":18,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.475331Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:7bb39832ea3508ddc7fe81632aac38ab73c87a7eefd63533e3f6439000a1fb63","observation_id":"08a2e22b-5f8a-4f3b-b138-26d52065529f","resolution":{"observed_at":"2026-08-14T04:16:28.270332Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.234322Z","title":"Nature Reviews Drug Discovery , volume =","venue":null,"work_id":"d1622460-2ede-4ff2-983b-d1daaaae05f0","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":19,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.480094Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:85222185f499f6406005239a845c9783c10312537381206f41b7b64eb807b20a","observation_id":"dfa18043-55f2-404c-a58e-01c69a6d164f","resolution":{"observed_at":"2026-08-14T04:16:28.244878Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.202401Z","title":"Highly Accurate Protein Structure Prediction with","venue":null,"work_id":"e04ac379-e863-448c-aac5-46aa421484ea","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":20,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.486923Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:be8438533036ab48b4cdcc5cfb11775042eec53b8b3a1553b71a8891d4ad4d9c","observation_id":"d97c3cef-48d0-4b3b-8976-5b1aee4e0ce1","resolution":{"observed_at":"2026-08-14T04:16:28.217450Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.183485Z","title":"and Grabowski, Henry G","venue":null,"work_id":"39efa31e-ba54-4ca8-8093-02584bb3cf5c","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":21,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.491529Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:73951b26166da3cf1cd947518544f47d3525610f3c92128228a2d7068ba28a48","observation_id":"0d16b0ed-66b2-4e70-87ae-8409663275ca","resolution":{"observed_at":"2026-08-14T04:16:28.188196Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.168681Z","title":", title =","venue":null,"work_id":"4bd21935-92bf-412c-b700-0d043b61c069","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":22,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.496045Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:2249f091ce561ef0db48cabe961cf560670cd2a67307ce06d60de4502418a7bd","observation_id":"231ee780-7b65-400c-812a-835cceae7703","resolution":{"observed_at":"2026-08-14T04:16:28.173399Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.150529Z","title":"and Craighead, John L","venue":null,"work_id":"5b7ce399-1446-4f1e-8a7e-36de0212627d","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":23,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.500292Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:43cbc6e56987c62a5d4b4c63d6227cff9826f5838d16990086456bb151799092","observation_id":"3e0d109e-4369-45c8-a1f8-fe48aa35a367","resolution":{"observed_at":"2026-08-14T04:16:28.155212Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.122413Z","title":"and Shamsuddin, Hala H","venue":null,"work_id":"5a7da582-2758-4962-918e-462e773503cf","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":24,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.504227Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:5dc159fdb6da8a5f2045684af7d8d896f05842d6d53b6d288959d686d98d45b8","observation_id":"629cba59-04e0-461a-aabe-f6c7dd2c259b","resolution":{"observed_at":"2026-08-14T04:16:28.134754Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.106178Z","title":null,"venue":null,"work_id":"9ac56b4f-21b7-435e-807a-6fe2dc803255","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":25,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.515174Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:0e4c9492af2180901fec7ffbb27a29c03d157f1ba7078a1995519ddd1f406737","observation_id":"b87dbe01-d40f-4f92-bb52-6cde3d2ab0b8","resolution":{"observed_at":"2026-08-14T04:16:28.110534Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.079236Z","title":"and Allison, Peter N","venue":null,"work_id":"8d7c6940-73b5-4dd3-8992-498fdbf08c52","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":26,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.521375Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:1aac701d4a0f0cd2728beabec53db4664097e6b2478bb1ed6221fc5bf0a8cdfe","observation_id":"9903da0d-2527-4dbb-afea-297748cb73c8","resolution":{"observed_at":"2026-08-14T04:16:28.083319Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.062465Z","title":"Nature Biotechnology , volume =","venue":null,"work_id":"6585c283-de49-4261-bed4-98a4d333315c","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":27,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.526766Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:dc864e8274ba78d8c4e19ad3eb38892ff20a5509c01549f82f38e0a166584043","observation_id":"715b0334-f46f-4bb3-bb26-0f008b05dea9","resolution":{"observed_at":"2026-08-14T04:16:28.067131Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.048237Z","title":", title =","venue":null,"work_id":"a7b25db1-c664-487c-91c8-ab62445574d7","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":28,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.531718Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:2176f4ec6f98c7e3c01e1f0ca0890d9d1e4c25051dea5fd56a41b4460adfa38f","observation_id":"664aafb6-414f-4450-9413-7d57dd4dbc43","resolution":{"observed_at":"2026-08-14T04:16:28.052645Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.033578Z","title":", title =","venue":null,"work_id":"b6319e87-3a05-4dc8-8825-82b21f77f39d","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":29,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.538103Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:71d9cde813d89fa8e12c898a6aa777f72e58d3e9766f41eae2d443c39e37c57b","observation_id":"0ce93ec3-a409-47b1-ba96-37b86ecdd512","resolution":{"observed_at":"2026-08-14T04:16:28.037883Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:28.010806Z","title":"2018 , month =","venue":null,"work_id":"3ccce5a7-f7ad-4aca-b817-f29bbebc069e","year":2018},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":30,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.542437Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:f5bc76a998b5e20d0321059512073e8f3967bdef987ca4e26a195848ec4b00d1","observation_id":"35e11421-c7b4-4ada-91a7-302dfbd6ada1","resolution":{"observed_at":"2026-08-14T04:16:28.020381Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:27.993697Z","title":"2023 , month =","venue":null,"work_id":"5529465d-abb2-4a12-8a7a-6bb019259555","year":2023},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":31,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.547671Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:89168a2a24d410fbd1ceffafbfa2bb9a800792eabc977e7ac4b1a00f4e06dfca","observation_id":"ccf39254-f5ad-49cc-b073-c4c981090622","resolution":{"observed_at":"2026-08-14T04:16:27.998372Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:27.979988Z","title":"and Dabora, Emil M","venue":null,"work_id":"012ee00c-4764-45da-a5d3-386039a35d70","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":32,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.552209Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:b1ef53eca4184d7ad10804fc24c33201b6cf990b935b8e1f0dbb3ceb20d6f8d4","observation_id":"acdb5a70-5910-46ee-bc76-263041f8f222","resolution":{"observed_at":"2026-08-14T04:16:27.984508Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:27.966208Z","title":"Speculative Trading and Stock Prices: Evidence from","venue":null,"work_id":"02d9f535-591a-43c6-8678-a330ed2d3fb7","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":33,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.556868Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:893155c6d85d87098829a2fd0b3d8643b0ecf38c02795e4e26b81dde6d88f5fb","observation_id":"5c269d5c-3431-4f6f-9c32-45fe76f14082","resolution":{"observed_at":"2026-08-14T04:16:27.970662Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:27.951762Z","title":"Andrew , title =","venue":null,"work_id":"a6a549ec-a088-4ea9-a50c-1450cf621384","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":34,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.561565Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:50634e5549ffc8b8c904f16d142d66fac0c1bdd61a9ae762279da64fb2855ede","observation_id":"a7cf1c4e-b21d-4fda-a8cf-916158bd779b","resolution":{"observed_at":"2026-08-14T04:16:27.956447Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:27.565440Z","title":"Science , volume =","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":35,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.565440Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:5eb1e6078a3e37db54e9b102abf46610544bef69d4970a41cd2656618a884bbd","observation_id":"d674972f-1ded-437c-8a15-6bef172ae4b4","resolution":{"observed_at":"2026-08-14T04:16:27.565440Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:27.917214Z","title":", title =","venue":null,"work_id":"b7be50a0-f8a6-4a44-bacf-06b564a1678e","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":36,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.570439Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:ed2842cfe6e5b8ec7af619cc48a6bcfaebed0e09662d7cb74db80f3822e24c2a","observation_id":"d762e1c5-470a-4c49-bf32-cd1b3d6a4628","resolution":{"observed_at":"2026-08-14T04:16:27.930545Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:27.901724Z","title":"and Odean, Terrance , title =","venue":null,"work_id":"de00dfce-5e2b-4ec5-bd34-16ebc6e235cb","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":37,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.574909Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:1859d632d554ad8939853db76beac3c84dea1d8c54e727f553a84a104d87a89a","observation_id":"6e734893-6f7a-4ccb-b9be-d7e74df0ec6d","resolution":{"observed_at":"2026-08-14T04:16:27.906094Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:27.888089Z","title":"Journal of Financial Economics , volume =","venue":null,"work_id":"0126bf4d-4503-492e-849c-ac3db8bcfdb1","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":38,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.579987Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:ff6880e1d6924444599247ebbd9753be2895f590df660f852d5107643008d7f9","observation_id":"cd0e655c-ac24-4487-90c8-a90d648b1678","resolution":{"observed_at":"2026-08-14T04:16:27.892188Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:27.872287Z","title":"Journal of Financial Economics , volume =","venue":null,"work_id":"abf0c00b-031a-4867-833e-cd809a77ac05","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":39,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.584871Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:4e312e5cd61ca03dd45c3087c0ca94e49d47878d39bd5f7dd67addcebc856f80","observation_id":"254098ff-d1d1-475e-86b9-a683f03bd212","resolution":{"observed_at":"2026-08-14T04:16:27.877513Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:27.857559Z","title":null,"venue":null,"work_id":"9f7a011b-6e8c-4aa4-b6aa-2be177153080","year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":40,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.589506Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:1d8bef2c48f1941ba2a8b8da9cc81b6bedc6b96618e23a8406b5088a6a538a82","observation_id":"58ca348c-8b05-4430-b987-d967dd6c0e47","resolution":{"observed_at":"2026-08-14T04:16:27.862831Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-14T06:32:32.682623+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-14T04:16:27.593627Z","title":"Nature Machine Intelligence , volume =","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology","version":1},"reference_index":41,"source":"arxiv_source","source_observed_at":"2026-08-14T04:16:27.593627Z"},"links":{"citing_paper":"/paper/2608.10175"},"observation_digest":"sha256:addcd0ec6d14b79d73d5fcd51636209518a5d8740ec35ef117b58f24892f1144","observation_id":"bee69829-9be8-4928-a7d1-e98d0c43e891","resolution":{"observed_at":"2026-08-14T04:16:27.593627Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}}],"paper":{"arxiv_id":"2608.10175","last_updated":"2026-08-10T19:44:29Z","latest_version":1,"primary_category":"cs.MA","snapshot_observed_at":"2026-08-14T23:10:15.888517Z","submitted_at":"2026-08-10T19:44:29Z","title":"Beyond Cash Flows: A Multi-Agent AI Framework for Valuing Clinical-Stage, Cross-Border Biotechnology"},"reference_resolution":{"displayed":41,"state_counts":{"malformed_identifier":0,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":14,"verified_exact":0,"verified_fuzzy":27},"total_outbound_references":41},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-14T06:32:32.682623+00:00","source":"crossref"},{"observed_at":"2026-08-14T06:32:18.44784+00:00","source":"retraction_watch"}],"thesis":"As of 14 August 2026, this Paper Citation Record lists 41 of 41 outbound references and 0 inbound Pith citation observations for arXiv:2608.10175."}